Here's How Much Eli Lilly's Weight-Loss Drugs Are Worth to Investors
Two drugs now generate almost two-thirds of the pharmaceutical giant's revenue.
Read the full articleYou might also wanna read
Eli Lilly’s $400 Billion Surge Is Reshaping Big Pharma
Roughly $400 billion. That is how much market value Eli Lilly (NYSE:LLY) has added over the past year, with shares climbing from $773.86 on
Hanmi Pharm Q2 Earnings to Improve on Lilly Upfront Payment
Hanmi Pharmaceutical is expected to beat Q2 expectations on a 112.9 billion won upfront payment from Eli Lilly, though core business recover
Eli Lilly Revenue Surges 55.5% on Mounjaro Sales, But Stock Lags Amid Pricing Pressures
Eli Lilly reported strong revenue growth and raised full-year guidance, but pricing pressure and insider selling have limited the stock’s ne
briefly.co·27d agoEli Lilly is reinventing the pharma business
The world’s largest drugmaker is betting big on preventive medicines—and learning from big tech
Wall Street Is Betting on Eli Lilly’s GLP-1 Portfolio — It’s Missing the $1 Trillion Opportunity
The pharmaceutical industry is entering a new era where biology and artificial intelligence are converging. Drug discovery, once a slow proc
Lilly Announces $2.8 Billion Psychedelics Acquisition
The deal values AtaiBeckley at $6.75 per share, a 26% premium over its previous closing price
Comments
Sign in to join the conversation.
No comments yet. Be the first.